유럽의 로봇 신경외과 시장 : 분석과 예측(2025-2035년)

This report can be delivered in 2 working days.

Introduction to Europe Robotic Neurosurgery Market

The Europe robotic neurosurgery market is projected to reach $585.3 million by 2035 and estimated $93.1 million in 2024, growing at a CAGR of 17.83% during the forecast period 2025-2035. The increasing prevalence of neurological disorders and the resulting need for sophisticated surgical techniques are major factors driving the growth of the robotic neurosurgery market in Asia-Pacific. Advances in AI-enabled guidance, real-time imagery integration, and precision robots are increasing application areas and enhancing results. Adoption is accelerating due to a regional shift towards minimally invasive techniques that reduce complications and shorten recovery times.

Market Introduction

The market for robotic neurosurgery in Europe is expected to increase steadily as medical professionals use more sophisticated technology to treat the growing number of neurological conditions. Surgeons can execute intricate treatments like deep brain stimulation (DBS), epilepsy mapping, and tumour resections with less tissue damage and more accuracy because to robotic systems' unmatched precision. Europe's well-established healthcare system, favourable payment policies, and increasing focus on minimally invasive procedures have all contributed to the continent's thriving industry.

The region's ageing population and the rise in neurological illnesses that goes along with it are major factors driving the demand for advanced surgical procedures. In addition to improving patient outcomes and reducing recovery periods, technological advancements like haptic feedback, real-time imaging integration, and AI-enhanced navigation are expanding the range of robotic applications. Prominent regional and international companies, including as Monteris Medical, Renishaw, Zimmer Biomet, and Medtronic, are actively working with academic institutions to improve workflow integration and demonstrate clinical efficacy.

High acquisition and maintenance costs, strict EU Medical Device Regulation (MDR) criteria for CE marking, and the demand for specialised surgeon training are some of the challenges facing the business despite its strong pace. However, it is anticipated that these difficulties will be lessened by continued investments in R&D and expanding surgical centre accreditation programs. The market for robotic neurosurgery in Europe is therefore expected to develop quickly because to innovation, harmonised regulations, and a shared drive for more precise, patient-centered care.

Market Segmentation

Segmentation 1: by Region

• Europe

U.K.

Germany

France

Italy

Spain

Rest-of-Europe

Europe Robotic Neurosurgery Market Trends, Drivers and Challenges

Market Trends

• Integration of AI-driven imaging and navigation platforms for enhanced precision and reduced errors
• Growth of multi-modal systems combining robotics with augmented reality and haptic feedback
• Increasing use of frameless stereotactic robots (e.g., ROSA) for minimally invasive neurosurgical procedures
• Miniaturization and modular robotic arms enabling flexible deployment in diverse OR environments

Key Drivers

• Rising prevalence of neurological disorders (e.g., Parkinson's, epilepsy, brain tumors)
• Favorable reimbursement policies and expanding healthcare budgets
• Clinical evidence showing reduced operative time, improved accuracy, and better patient outcomes
• Growth of specialized neurosurgical centers and training programs

Major Challenges

• High acquisition and maintenance costs limiting access for smaller hospitals
• Steep learning curves and shortage of trained neurosurgical robotics teams
• Regulatory and CE-marking complexities delaying market entry
• Integration hurdles with legacy IT systems and cybersecurity concerns

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Brainlab AG
• Renishaw plc
• Medtronic plc.

Table of Contents

Executive Summary

Scope and Definition

1 Europe Robotic Neurosurgery Market: Industry Outlook

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
  • 1.1.2 Significant Number of Collaborations among Market Players
  • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
• 1.2 Supply Chain Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
  • 1.3.2 U.K.
• 1.4 Pricing Analysis
• 1.5 Funding Scenario
• 1.6 Market Dynamics
  • 1.6.1 Market Drivers
    • 1.6.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
    • 1.6.1.2 Rising Prevalence of Neurological Disorders
    • 1.6.1.3 Continuous Technological Advancements in Robotic Neurosurgery
  • 1.6.2 Market Restraints
    • 1.6.2.1 High Cost of Investment
    • 1.6.2.2 Lack of Skilled Professionals
  • 1.6.3 Market Opportunities
    • 1.6.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Robotic Neurosurgery Market (by Region), $Million, 2023-2035

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Procedure Volume
  • 2.2.5 Germany
  • 2.2.6 Spain
  • 2.2.7 U.K.
  • 2.2.8 Rest-of-Europe

3 Markets - Product Profiles

• 3.1 Renishaw plc
  • 3.1.1 Product Overview
  • 3.1.2 Launch Year
  • 3.1.3 Key Features
  • 3.1.4 Key Parameter
  • 3.1.5 Installed Base
  • 3.1.6 Unit Sold
• 3.2 Zimmer Biomet Holdings, Inc.
  • 3.2.1 Product Overview
  • 3.2.2 Launch Year
  • 3.2.3 Key Features
  • 3.2.4 Key Parameter
  • 3.2.5 Installed Base
  • 3.2.6 Unit Sold

4 Markets - Competitive Benchmarking & Company Profiles

• 4.1 Product Benchmarking
• 4.2 Key Strategies and Development
• 4.3 Company Profiles
  • 4.3.1 Brainlab AG
    • 4.3.1.1 Overview
    • 4.3.1.2 Top Products/Product Portfolio
    • 4.3.1.3 Top Competitors
    • 4.3.1.4 Target Customers
    • 4.3.1.5 Key Personal
    • 4.3.1.6 Analyst View
  • 4.3.2 Renishaw plc
    • 4.3.2.1 Overview
    • 4.3.2.2 Top Products/Product Portfolio
    • 4.3.2.3 Top Competitors
    • 4.3.2.4 Target Customers
    • 4.3.2.5 Key Personal
    • 4.3.2.6 Analyst View
  • 4.3.3 Medtronic plc
    • 4.3.3.1 Overview
    • 4.3.3.2 Top Products/Product Portfolio
    • 4.3.3.3 Top Competitors
    • 4.3.3.4 Target Customers
    • 4.3.3.5 Key Personal
    • 4.3.3.6 Analyst View

5 Research Methodology

• 5.1 Data Sources
  • 5.1.1 Primary Data Sources
  • 5.1.2 Secondary Data Sources
  • 5.1.3 Data Triangulation
• 5.2 Market Estimation and Forecast